FDA Announces CDRH’s OST is Now Super Office within the Center

Jan. 29, 2024
The Super Office designation allows the Center, specifically OST, to be well-positioned and capable of adapting to and addressing future public health needs and challenges

On Jan. 24, the FDA announced organizational changes within the Center for Devices and Radiological Health (CDRH). Effective immediately, CDRH’s Office of Strategic Partnerships and Technology Innovation (OST) has been elevated to a Super Office within the Center.

The new structure allows the center, specifically OST, to be well-positioned and capable of adapting to and addressing future public health needs and challenges while continuing to advance the voice of patients, innovation and safety, regulatory science, and service excellence with our customers.

FDA has the news.

Photo 170554520 | Business © Kseniia Kolesnikova | Dreamstime.com
ID 154742479 © Pop Nukoonrat | Dreamstime.com
Photo 284411646 | Ai Healthcare © Yuri Arcurs | Dreamstime.com
557322636 © 2ragon | stock.adobe.coom